Skip to main content
OpenTrials

Clinical trial condition

Gastric or Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastric or Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

19 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Gastric or Gastroesophageal Junction Adenocarcinoma trial results

Recruiting

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

NCT05482893

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +6 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute (SCRI) Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

NCT06841679

Conditions
Gastric or Gastroesophageal Junction Adenocarcinoma
Locations
  • Bioresearch Partner Hialeah, Florida, United States
  • AnYang Tumor Hospital Anyang, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Jinan Municipal Central Hospital Jinan, China
View Trial Details

Related conditions